Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Mitchell

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Hepatology (Baltimore, Md.)|June 20, 2020
Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated HepatitisXiude Fan, Rebecca L McCullough, Emily Huang, et al.
Hepatology Communications|October 11, 2023
Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver diseaseMarko Mrdjen, Emily Huang, Vai Pathak, et al.
The American Journal of Gastroenterology|April 3, 2023
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated HepatitisTarek Hassanein, Craig J McClain, Vatsalya Vatsalya, et al.
Bioinformatics (Oxford, England)|June 30, 2026
Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and MediatorsXincheng Li, Maiying Kong, Matthew Ryan Smith, et al.
JCI Insight|February 22, 2021
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humansTatsunori Miyata, Xiaoqin Wu, Xiude Fan, et al.
JCI Insight|December 8, 2022
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humansTatsunori Miyata, Xiaoqin Wu, Xiude Fan, et al.
Hepatology (Baltimore, Md.)|July 19, 2024
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisoneKavish R Patidar, Wanzhu Tu, Thomas G Cotter, et al.
NEJM Evidence|January 28, 2025
Larsucosterol for the Treatment of Alcohol-Associated HepatitisMitchell Shiffman, Ben Da, Aparna Goel, et al.
The American Journal of Pathology|May 12, 2026
SIRPa cleavage is associated with inflammatory response, corticosteroid non-response, and worse prognosis in clinical and pre-clinical models of alcohol-associated hepatitisEthan R Steele, Dylan Nunn, David Malicote, et al.
Elife|January 27, 2022
Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in miceRobert N Helsley, Tatsunori Miyata, Anagha Kadam, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Hepatology (Baltimore, Md.)|June 20, 2020
Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated HepatitisXiude Fan, Rebecca L McCullough, Emily Huang, et al.
Hepatology Communications|October 11, 2023
Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver diseaseMarko Mrdjen, Emily Huang, Vai Pathak, et al.
The American Journal of Gastroenterology|April 3, 2023
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated HepatitisTarek Hassanein, Craig J McClain, Vatsalya Vatsalya, et al.
Bioinformatics (Oxford, England)|June 30, 2026
Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and MediatorsXincheng Li, Maiying Kong, Matthew Ryan Smith, et al.
JCI Insight|February 22, 2021
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humansTatsunori Miyata, Xiaoqin Wu, Xiude Fan, et al.
JCI Insight|December 8, 2022
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humansTatsunori Miyata, Xiaoqin Wu, Xiude Fan, et al.
Hepatology (Baltimore, Md.)|July 19, 2024
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisoneKavish R Patidar, Wanzhu Tu, Thomas G Cotter, et al.
NEJM Evidence|January 28, 2025
Larsucosterol for the Treatment of Alcohol-Associated HepatitisMitchell Shiffman, Ben Da, Aparna Goel, et al.
The American Journal of Pathology|May 12, 2026
SIRPa cleavage is associated with inflammatory response, corticosteroid non-response, and worse prognosis in clinical and pre-clinical models of alcohol-associated hepatitisEthan R Steele, Dylan Nunn, David Malicote, et al.
Elife|January 27, 2022
Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in miceRobert N Helsley, Tatsunori Miyata, Anagha Kadam, et al.
Pageof 2